Resmed RSMDF
NYSE RSMDF
$22.61 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Resmed (RSMDF) Non-Current Assets (2010 - 2026)

Resmed's (RSMDF) quarterly Non-Current Assets came in at $4.6 billion in Q2 2026, down 0.59% on a YoY basis from $4.7 billion in Q2 2025, and down 1.67% quarter-over-quarter from $4.7 billion in Q1 2026.

Analysis

Resmed (RSMDF) Non-Current Assets (2010 - 2026) Analysis & Trends

Resmed (RSMDF) has reported Non-Current Assets for 17 consecutive years, with $4.6 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non-Current Assets fell 0.59% year-over-year to $4.6 billion; the trailing twelve-month figure through Jun 2026 stood at $4.6 billion (down 0.59% YoY), and the FY2026 full-year result was $4.6 billion, down 0.59% from the prior year.
  • Non-Current Assets eased to $4.6 billion in Q2 2026 per RSMDF's latest filing, from $4.7 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $4.7 billion in Q1 2026 and bottomed at $3.1 billion in Q3 2022.
  • Historically, Non-Current Assets has averaged $4.3 billion across 5 years, with a median of $4.4 billion in 2023.
  • The sharpest annual moves came in 2023 and 2024: Non-Current Assets soared 41.11% in 2023, then decreased 4.9% in 2024.
  • Over 5 years, Non-Current Assets stood at $4.4 billion in 2022, then grew by 4.05% to $4.5 billion in 2023, then dropped by 4.9% to $4.3 billion in 2024, then grew by 8.81% to $4.7 billion in 2025, then retreated by 0.93% to $4.6 billion in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $4.6 billion, $4.7 billion, and $4.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Abbott Laboratories 183.94 Bn 178.34 Bn 7.27 Bn 84.70 Bn
2 Intuitive Surgical 124.29 Bn 119.08 Bn 1.96 Bn 11.33 Bn
3 Medtronic 118.22 Bn 109.40 Bn 6.34 Bn 68.92 Bn
4 Stryker 104.52 Bn 101.04 Bn 4.50 Bn 33.51 Bn
5 Boston Scientific 66.33 Bn 65.79 Bn 3.85 Bn 37.24 Bn
6 Edwards Lifesciences 49.61 Bn 45.35 Bn 1.35 Bn 7.05 Bn
7 Alcon 33.94 Bn 32.49 Bn 1.68 Bn 24.47 Bn
8 Dexcom 32.18 Bn 30.23 Bn 830.00 Mn 2.37 Bn
9 Steris 21.13 Bn 20.65 Bn 684.20 Mn 8.29 Bn
10 Resmed 3.54 Bn 2.07 Bn 861.22 Mn 4.64 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.64 Bn
Mar 31, 2026 4.72 Bn
Dec 31, 2025 4.68 Bn
Sep 30, 2025 4.68 Bn
Jun 30, 2025 4.67 Bn
Mar 31, 2025 4.36 Bn
Dec 31, 2024 4.31 Bn
Sep 30, 2024 4.58 Bn
Jun 30, 2024 4.51 Bn
Mar 31, 2024 4.46 Bn
Dec 31, 2023 4.53 Bn
Sep 30, 2023 4.44 Bn
Jun 30, 2023 4.38 Bn
Mar 31, 2023 4.38 Bn
Dec 31, 2022 4.35 Bn
Sep 30, 2022 3.14 Bn
Jun 30, 2022 3.16 Bn
Mar 31, 2022 3.20 Bn
Dec 31, 2021 3.19 Bn
Sep 30, 2021 3.14 Bn